BioCentury
ARTICLE | Financial News

Spero raises $51.7M in series C

March 8, 2017 11:21 PM UTC

Anti-infective play Spero Therapeutics LLC (Cambridge, Mass.) raised $51.7 million in a series C round led by new investor GV. Also participating were new investors RA Capital Management and Rock Springs Capital, as well as existing investors Atlas Venture, SR One, MRL Ventures, Lundbeckfonden Ventures, the Kraft Group and Osage University Partners...

BCIQ Company Profiles

Spero Therapeutics Inc.